Dr. Lelivelt has over 15 years of experience is using genomic scale assays to address scientific questions. In 1991, he received Bachelor’s degrees in both Mathematics and Biology from Augustana College in Rock Island, IL including independent research on microbial pathogenesis. He continued his interest in how bacteria can negatively affect their hosts by studying the genetic regulation pilus expression within E. coli at the University of North Carolina at Chapel Hill where he earned a Ph.D from the Medical School. Dr. Lelivelt continued his research on genetics systems in his postdoctoral work at the University of Wisconsin – Madison in the laboratory of Michael Culbertson on the global effects of mutations inhibiting the nonsense-mediated decay (NMD) pathway within S. cerevisiae. During his post-doctoral work in 1996-1998, Dr. Lelivelt worked in collaboration with Affymetrix to use microarrays to study the global transcription impact of these NMD mutants.
Following the completion of his post-doctoral work, Dr. Lelivelt turned his attention to the growing industry of commercial tool providers that helped enhance a broader class of research. He worked at Affymetrix from 1999 through 2007 and acted in a variety of roles including field support, support management, and sales specialists. He spent the second half of his tenure at Affymetrix building the GeneChip-compatible Program - a network of data analysis providers and the Affymetrix Developers’ Network – an open network of software developers using a collection of open source tools from Affymetrix to help encourage development of software to consume large scale genomic data.
Dr. Lelivelt then spent two years (2008-2009) at Partek, a small privately held company focused on building genomic software tools for analysis and visualization of genomic, transcriptomic, and regulomic data from microarrays and next-generation sequencing. He held the role of vice president of Genomics at Partek and managed both the support organization as well as guiding the product development process. Dr. Lelivelt was also foundational in building the European field organization for Partek.
In 2010, Dr. Lelivelt joined Ion Torrent as one of the founding members of the commercial organization. Today, following the acquisition of Ion Torrent by Life Technologies, he is Director of Bioinformatics and Software Products. He leads the direction of Torrent Suite Software and manages all the external relationships with a variety of analysis partners who consume and analyze semiconductor sequencing data.
Mike lives in Wisconsin with his wife and three children and enjoys road cycling and cooking for his family.